Literature DB >> 24851126

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression.

Kenji Hashimoto1.   

Abstract

Entities:  

Year:  2014        PMID: 24851126      PMCID: PMC4022771          DOI: 10.9758/cpn.2014.12.1.72

Source DB:  PubMed          Journal:  Clin Psychopharmacol Neurosci        ISSN: 1738-1088            Impact factor:   2.582


× No keyword cloud information.
  7 in total

1.  Therapeutic implications for NMDA receptors in mood disorders.

Authors:  Kenji Hashimoto
Journal:  Expert Rev Neurother       Date:  2013-07       Impact factor: 4.618

2.  Ketamine for treatment-resistant depression: ready or not for clinical use?

Authors:  A John Rush
Journal:  Am J Psychiatry       Date:  2013-10       Impact factor: 18.112

3.  R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine.

Authors:  Ji-Chun Zhang; Su-Xia Li; Kenji Hashimoto
Journal:  Pharmacol Biochem Behav       Date:  2013-12-03       Impact factor: 3.533

4.  Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET).

Authors:  F X Vollenweider; K L Leenders; I Oye; D Hell; J Angst
Journal:  Eur Neuropsychopharmacol       Date:  1997-02       Impact factor: 4.600

5.  Taming the ketamine tiger. 1965.

Authors:  Edward F Domino
Journal:  Anesthesiology       Date:  2010-09       Impact factor: 7.892

6.  Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

Authors:  James W Murrough; Dan V Iosifescu; Lee C Chang; Rayan K Al Jurdi; Charles E Green; Andrew M Perez; Syed Iqbal; Sarah Pillemer; Alexandra Foulkes; Asim Shah; Dennis S Charney; Sanjay J Mathew
Journal:  Am J Psychiatry       Date:  2013-10       Impact factor: 18.112

Review 7.  Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.

Authors:  John H Krystal; Gerard Sanacora; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2013-06-15       Impact factor: 13.382

  7 in total
  18 in total

1.  Blood D-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine.

Authors:  Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2014-09-05       Impact factor: 4.530

2.  Rapid antidepressant effects and abuse liability of ketamine.

Authors:  Chun Yang; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2014-03-26       Impact factor: 4.530

3.  Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.

Authors:  Ji-chun Zhang; Wei Yao; Chao Dong; Chun Yang; Qian Ren; Min Ma; Mei Han; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2015-09-04       Impact factor: 4.530

Review 4.  Inflammatory biomarkers as differential predictors of antidepressant response.

Authors:  Kenji Hashimoto
Journal:  Int J Mol Sci       Date:  2015-04-08       Impact factor: 5.923

5.  Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.

Authors:  Bangkun Yang; Ji-Chun Zhang; Mei Han; Wei Yao; Chun Yang; Qian Ren; Min Ma; Qian-Xue Chen; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2016-08-04       Impact factor: 4.530

Review 6.  Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets.

Authors:  Ji-Chun Zhang; Wei Yao; Kenji Hashimoto
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

7.  Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model.

Authors:  Bangkun Yang; Qian Ren; Min Ma; Qian-Xue Chen; Kenji Hashimoto
Journal:  Int J Neuropsychopharmacol       Date:  2016-12-30       Impact factor: 5.176

8.  Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major Depression.

Authors:  Chun Yang; Kenji Hashimoto
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-04-30       Impact factor: 2.582

9.  BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms.

Authors:  Q Ren; M Ma; C Yang; J-C Zhang; W Yao; K Hashimoto
Journal:  Transl Psychiatry       Date:  2015-10-27       Impact factor: 6.222

10.  R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.

Authors:  C Yang; Y Shirayama; J-c Zhang; Q Ren; W Yao; M Ma; C Dong; K Hashimoto
Journal:  Transl Psychiatry       Date:  2015-09-01       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.